Nutex Health Inc. (NASDAQ:NUTX) Given Average Recommendation of “Buy” by Analysts

Posted by Geri Gentry on Sep 21st, 2026

Shares of Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) have earned a consensus rating of “Buy” from the five brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $317.50.

Several research firms have weighed in on NUTX. Zacks Research upgraded Nutex Health from a “hold” rating to a “strong-buy” rating in a report on Monday, August 24th. B Riley reissued a “buy” rating on shares of Nutex Health in a research note on Friday, September 4th. B. Riley Financial upped their target price on Nutex Health from $290.00 to $325.00 and gave the company a “buy” rating in a report on Friday, September 4th. Wall Street Zen cut shares of Nutex Health from a “buy” rating to a “hold” rating in a report on Saturday, September 5th. Finally, Lake Street Capital reissued a “buy” rating and set a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th.

View Our Latest Report on NUTX

Nutex Health Price Performance

Nutex Health stock opened at $208.79 on Monday. The business has a fifty day moving average price of $179.58 and a 200-day moving average price of $143.96. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96. Nutex Health has a one year low of $83.99 and a one year high of $224.28. The firm has a market capitalization of $1.43 billion, a P/E ratio of 8.20 and a beta of 0.28.

Nutex Health (NASDAQ:NUTX – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The firm had revenue of $210.75 million during the quarter, compared to the consensus estimate of $215.03 million. As a group, equities research analysts forecast that Nutex Health will post 27.58 EPS for the current year.

Insider Buying and Selling at Nutex Health

In other Nutex Health news, Director Scott Saunders sold 203 shares of the company’s stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $214.25, for a total transaction of $43,492.75. Following the transaction, the director owned 400 shares in the company, valued at approximately $85,700. This represents a 33.67% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 44.68% of the company’s stock.

Institutional Trading of Nutex Health

A number of hedge funds have recently modified their holdings of NUTX. Quantinno Capital Management LP bought a new stake in shares of Nutex Health in the 1st quarter worth approximately $843,000. First Trust Advisors LP increased its holdings in Nutex Health by 60.0% in the 1st quarter. First Trust Advisors LP now owns 18,335 shares of the company’s stock worth $1,743,000 after buying an additional 6,874 shares in the last quarter. Winmill & CO. Inc. bought a new position in Nutex Health during the second quarter valued at approximately $11,168,000. Corient Private Wealth LP purchased a new position in Nutex Health in the second quarter worth about $1,142,000. Finally, Empowered Funds LLC bought a new position in Nutex Health in the first quarter worth approximately $3,084,000. Institutional investors own 5.32% of the company’s stock.

About Nutex Health

(Get Free Report)

Nutex Health Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, outpatient facilities and physician practices. The company focuses on delivering emergency, inpatient and outpatient care through community-based healthcare facilities, including micro-hospitals designed to provide essential hospital services in convenient local settings.

Its services may include emergency medicine, primary care, specialty care, diagnostic testing, imaging, laboratory services and other ancillary healthcare offerings.